Delivery Order SPE2DR25D3004-SPE2DR26FXSG2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,705.28 to AmerisourceBergen Drug Corp for Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. This firm fixed price delivery order, which became effective on October 28, 2025, with a completion date of October 29, 2025, represents a small-value transaction under AmerisourceBergen's larger contract portfolio with the agency. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,814.91 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This non-competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $1,352.64 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,352.64 for Omnipaque 350 mg/ml Pluspak 500ml, a contrast agent used in diagnostic imaging procedures. The contract is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,381.60 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Omnipaque 350 mg/mL PlusPak 500 mL, a contrast medium used in medical imaging procedures. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. Performance will be completed by June 3, 2025, and fulfillment will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Omnipaque 300 mg/mL Pluspak 500mL contrast media, with a contract ceiling value of $1,141.62. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $5,090.26 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml in 500ml Pluspak units, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a single delivery order under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $3,043.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500ml, a contrast medium used in medical imaging procedures. This is a non-set-aside, competitively awarded contract with a completion date of June 17, 2025, and performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,467.90 to supply Omnipaque 300 mg/ml in 30ml containers. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award practices. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXSG2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,140.48 to supply Omnipaque 350 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. The award, issued on January 2, 2026, represents a firm fixed price delivery order with an ultimate completion date of January 5, 2026. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a substantial ceiling value of $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen demonstrates significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/1/26 |